Fig. 2.
Incidences of medications that were stopped upon treatment with SLIT and those that were continued (effectiveness set; n = 200). SLIT sublingual immunotherapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.